Boom

CordenPharma produces lipid product DOTAP Cl - CAS# 13 - Item # LP-R4-117 - MW 698.54.

Following remarkable growth, CordenPharma announces the launch of enhanced GMP capacities in Frankfurt, aiming to streamline peptide-based drug development for pharma …

With our recently established GMP LNP manufacturing plant, your project will benefit from our complementary services for consecutive LNP formulation and batch-filling processes, all under one roof. This integrated approach helps minimize production time for your clinical material to ensure a more streamlined and effective process.

CordenPharma's Highly Potent Oral Solid Drug Product Centre of Excellence in CordenPharma Plankstadt (DE). "This is an extremely important and significant investment for CordenPharma Plankstadt. The new CTD 4 facility will bridge the gap between our small-scale GMP and larger commercial production facilities.

Joining three other CTD facilities, each focused on either R&D formulation development or small-scale GMP manufacturing, the new facility will bridge the scale gap between these smaller scales and the two large-scale production facilities to manufacture GMP batches up to 60 kg.

Partnership for the Manufacture of Lipids, pDNA / xRNA, LNP Manufacturing & Injectables. CordenPharma and WACKER have formed a strategic partnership to create a unique, fully-integrated service covering the complete supply chain from early clinical to commercial stage development and manufacturing of xRNA-based vaccines and gene therapies, including final …

This video presents our new cGMP Lipid NanoParticle (LNP) manufacturing facility in Caponago, Italy. The FDA / EMA approved site builds on decades of sterile injectable experience and fully supplements our already …

Take a look inside the construction of our new API development building at CordenPharma Bergamo. This state-of-the-art facility covers a full range of services and activities from API process assessment & development at laboratory scale through to scale-up and subsequent transfer of our customers' processes into commercial facilities.

CordenPharma Bergamo (IT) is a cGMP manufacturer of APIs, advanced pharmaceutical intermediates, and custom lipids, specializing in the large-scale commercial manufacturing of APIs for distribution on a global scale. ... CordenPharma Frankfurt supplies seamless integration with our larger scale GMP peptide manufacturing site CordenPharma ...

CordenPharma is a leading CDMO for cGMP development & manufacturing of APIs, lipid excipients, drug products, injectables, peptides, LNPs, oligos, & osd.

The CordenPharma Solid State Centre of Excellence, located at our Liestal, Switzerland site, provides extensive solid-state API development support services tailored to your project needs. Our dedicated team of crystallization process and solid-state form experts, combined with the latest technology and equipment, allows for a bespoke offering that …

My name is Gudrun Schumacher, and I joined CordenPharma in January 2023 as the Global Head of Human Resources. Over the past few months, I have had the chance to speak with many colleagues to gain a deeper understanding of CordenPharma's people, brand, culture, mission, and value proposition to customers as full-service CDMO.

The GMP manufacturing area is designed to produce peptide APIs from gram to kilogram range for clinical phase 1 and 2 requirements. CordenPharma Boosts Peptide API Production with …

CordenPharma TSAB members Dr. Olivia Merkel and Dr. José de Chastonay discuss the future of pharma drug delivery and Artificial Intelligence for CDMOs. ... it became clear that a focus on increased integration of our robust API, Lipid Excipient and Drug Product development and manufacturing services is key to mastering future challenges, where ...

CordenPharma is a leading CDMO for GMP API manufacturing of peptides, oligos, HPAPIs and small molecules. Partner with us for your API manufacturing needs.

Our sterile injectable cGMP facility has a long track record of experience in the production of highly potent sterile liquids in vials. The site offers technology transfer and manufacturing, and is comprised of two independent facilities: one for clinical supplies up to 10,000 units per batch, and the other facility with two commercial-scale filling lines, one which is fully dedicated to vials.

Interview on CordenPharma Lisbon's environmental sustainability & drug product manufacturing capacity for tablets, capsules & ointments.

CordenPharma is a leading CDMO for GMP API manufacturing of peptides, oligos, HPAPIs and small molecules. Partner with us for your API manufacturing needs.

At CPHI Milan 2024, Outsourcing-Pharma interviewed Dr. Brittany L. Hayes, Director, Global Highly Potent & Oncology Platform and Dr. Ilia Freifeld, Director, Global Small Molecules Platform on how CordenPharma addresses the challenges and synergies in API and Drug Product development, including innovative technologies such as spray drying, hot ...

CordenPharma has announced the commissioning of new GMP capacities at its Frankfurt site to manufacture early clinical phase peptide APIs. The investment is still being …

Harnessing the collective expertise of teams across our globally-integrated cGMP facility network, we provide bespoke outsourcing services spanning the complete supply chain of APIs, drug …

CordenPharma is the CDMO partner you need for the reliable supply of complex modalities along your drug development lifecycle. Harnessing the collective expertise of teams across our globally-integrated cGMP facility network, we …

The GMP manufacturing area is designed to produce peptide APIs from gram to kilogram range for clinical phase 1 and 2 requirements. Lipids & Carbohydrates Platform: Investments to Drive the Creation of New Complex Modalities ... Phase 2 includes the design and construction of a larger GMP manufacturing facility at CordenPharma Chenôve, with a ...

CordenPharma is a full-service CDMO for the global market, providing expert support for the development and manufacturing of APIs, Excipients, Drug Products, and associated Packaging Services. ... scale-up and commercial cGMP manufacturing of APIs, Drug Products, and Lipid Excipients. 11 Manufacturing Facilities.

CordenPharma is a leading CDMO for GMP API manufacturing of peptides, oligos, HPAPIs and small molecules. Partner with us for your API manufacturing needs. ... Through years of experience supplying complex APIs, CordenPharma has targeted and developed specialized API support services to make your API project journey run as smoothly and ...

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

When it comes to small molecule outsourcing, choosing a reliable, flexible and robust CDMO is crucial for securing your supply chain. With a proven track record and decades of expertise, our Small Molecules platform provides comprehensive small molecule API and drug product development and manufacturing across a wide range of commercial therapeutics.

APIs. API Support Services; Flow Chemistry; Solid State; Purification; Drug Products. ... Our Lipid NanoParticle (LNP) formulation development and GMP manufacturing services range from clinical to commercial supply, fully integrated with aseptic fill and finish sterile injectable manufacturing capacities, all within the same site ...

CordenPharma executives interview new Private Equity owners Astorg on joint plans to strengthen CAPEX, operations and CDMO strategy. ... Secondly, it has a leadership position in its most strategic platforms such as lipids, peptides, and highly potent APIs. It has a very specific and distinctive one-stop-shop offering, with end-to-end ...

Our GMP sterile injectable facility provides formulation development and manufacturing for aseptic and terminal sterilization fill and finish in pre-filled Syringes (PFS), ampoules, liquid …